Otsuka America Pharmaceutical, Inc.
Registered Principal Details
Business Or Interest:
Healthcare company driven by our purpose and defined by our beliefs. Working with key state stakeholders to make access to healthcare more accessible for patients in our disease states including neuroscience and nephrology.
Lobbying Interests:
Healthcare, Rare Disease, Access to healthcare, Prescription drugs, Behavioral Health
CEO Name:
Tarek Rabah
Healthcare company driven by our purpose and defined by our beliefs. Working with key state stakeholders to make access to healthcare more accessible for patients in our disease states including neuroscience and nephrology.
Lobbying Interests:
Healthcare, Rare Disease, Access to healthcare, Prescription drugs, Behavioral Health
CEO Name:
Tarek Rabah
Contact
JL
Joee Lindbeck
508 Carnegie Center Drive
Princeton, NJ 08540
(703) 684-1110
compliance_WI_otsuka@multistate.us
http://www.otsuka-us.com
508 Carnegie Center Drive
Princeton, NJ 08540
(703) 684-1110
compliance_WI_otsuka@multistate.us
http://www.otsuka-us.com
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 54
Toggle details
Assembly Bill 54
Relating to: utilization management controls for antipsychotic prescription drugs under the Medical Assistance program. (FE)
Bill Text and History
2/27/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: utilization management controls for antipsychotic prescription drugs under the Medical Assistance program. (FE)
Bill Text and History
For
Notification Date2/27/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 173
Toggle details
Assembly Bill 173
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
4/11/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
For
Notification Date4/11/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 83
Toggle details
Senate Bill 83
Relating to: utilization management controls for antipsychotic prescription drugs under the Medical Assistance program. (FE)
Bill Text and History
2/27/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: utilization management controls for antipsychotic prescription drugs under the Medical Assistance program. (FE)
Bill Text and History
For
Notification Date2/27/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 203
Toggle details
Senate Bill 203
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
4/21/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
For
Notification Date4/21/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Budget Bill Subjects
Biennial budget bill treatment of matter relating to
Health Services: Departmentwide
Health Services: Departmentwide
Notification Date
2/21/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
2/21/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Biennial budget bill treatment of matter relating to
Health Services: Medicaid Services
Health Services: Medicaid Services
Notification Date
2/21/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
2/21/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Biennial budget bill treatment of matter relating to
Insurance: Supervision of the Insurance Industry
Insurance: Supervision of the Insurance Industry
Notification Date
2/21/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
2/21/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
Mental Health Protections and Parity
Mental Health Protections and Parity
Notification Date
1/6/2025
First Communication Date
1/6/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
1/6/2025
First Communication Date
1/6/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Development, drafting or introduction of a proposal relating to
2025-2027 Biennial Budget Bill
2025-2027 Biennial Budget Bill
Notification Date
1/6/2025
First Communication Date
1/6/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
1/6/2025
First Communication Date
1/6/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Total Lobbying Effort
| 2025 January - June |
2025 July - December |
Total | |
|---|---|---|---|
| Total Lobbying Expenditures | 2025 January - June $27,104.15 |
2025 July - December $31,805.56 |
Total $58,909.71 |
| Total Hours Communicating | 2025 January - June 22.90 |
2025 July - December 24.05 |
Total 46.95 |
| Total Hours Other | 2025 January - June 76.70 |
2025 July - December 85.40 |
Total 162.10 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
| 2025 January - June |
2025 July - December |
2026 January - June |
2026 July - December |
Total |
|---|---|---|---|---|
| 2025 January - June 3% |
2025 July - December 8% |
2026 January - June |
2026 July - December |
Total 6% |
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
| 2025 January - June |
2025 July - December |
2026 January - June |
2026 July - December |
Total |
|---|---|---|---|---|
| 2025 January - June 11% |
2025 July - December 8% |
2026 January - June |
2026 July - December |
Total 10% |
Relating to: utilization management controls for antipsychotic prescription drugs under the Medical Assistance program. (FE)
| 2025 January - June |
2025 July - December |
2026 January - June |
2026 July - December |
Total |
|---|---|---|---|---|
| 2025 January - June 28% |
2025 July - December 21% |
2026 January - June |
2026 July - December |
Total 24% |
Relating to: utilization management controls for antipsychotic prescription drugs under the Medical Assistance program. (FE)
| 2025 January - June |
2025 July - December |
2026 January - June |
2026 July - December |
Total |
|---|---|---|---|---|
| 2025 January - June 28% |
2025 July - December 21% |
2026 January - June |
2026 July - December |
Total 24% |
Budget Bill Subjects
| 2025 January - June |
2025 July - December |
2026 January - June |
2026 July - December |
Total |
|---|---|---|---|---|
| 2025 January - June |
2025 July - December 1% |
2026 January - June |
2026 July - December |
Total < 1% |
| 2025 January - June |
2025 July - December |
2026 January - June |
2026 July - December |
Total |
|---|---|---|---|---|
| 2025 January - June |
2025 July - December 2% |
2026 January - June |
2026 July - December |
Total < 1% |
| 2025 January - June |
2025 July - December |
2026 January - June |
2026 July - December |
Total |
|---|---|---|---|---|
| 2025 January - June |
2025 July - December 2% |
2026 January - June |
2026 July - December |
Total < 1% |
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
| 2025 January - June |
2025 July - December |
2026 January - June |
2026 July - December |
Total |
|---|---|---|---|---|
| 2025 January - June 30% |
2025 July - December 4% |
2026 January - June |
2026 July - December |
Total 16% |
| 2025 January - June |
2025 July - December |
2026 January - June |
2026 July - December |
Total |
|---|---|---|---|---|
| 2025 January - June |
2025 July - December 5% |
2026 January - June |
2026 July - December |
Total 3% |
Minor Efforts
(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication